KRISTEN HEGGINS: Open Payments
NPI 1598274219 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 25 payments from 9 companies in 2025. Trend: 2023 $466 · 2024 $654 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $202 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| Philips North America LLC | 1 | $24 |
| Abbott Laboratories | 1 | $20 |
| ABIOMED | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: CAMZYOS, LEQVIO, ELIQUIS, Ambulatory Monitoring & Diagnostics Undivided, MERLIN@HOME, EVENITY, JARDIANCE, MOUNJARO.
Industry payments across MS — which companies pay providers there.
